Home Other Building Blocks 3,8-Dihydroxy-6H-benzo[c]chromen-6-one

3,8-Dihydroxy-6H-benzo[c]chromen-6-one

CAS No.:
1143-70-0
Catalog Number:
AG000B0X
Molecular Formula:
C13H8O4
Molecular Weight:
228.2002
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
100mg
98%
In Stock USA
United States
$157
- +
250mg
98%
In Stock USA
United States
$238
- +
1g
98%
In Stock USA
United States
$588
- +
Product Description
Catalog Number:
AG000B0X
Chemical Name:
3,8-Dihydroxy-6H-benzo[c]chromen-6-one
CAS Number:
1143-70-0
Molecular Formula:
C13H8O4
Molecular Weight:
228.2002
MDL Number:
MFCD20275235
IUPAC Name:
3,8-dihydroxybenzo[c]chromen-6-one
InChI:
InChI=1S/C13H8O4/c14-7-1-3-9-10-4-2-8(15)6-12(10)17-13(16)11(9)5-7/h1-6,14-15H
InChI Key:
RIUPLDUFZCXCHM-UHFFFAOYSA-N
SMILES:
Oc1ccc2c(c1)oc(=O)c1c2ccc(c1)O
Properties
Complexity:
317  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
228.042g/mol
Formal Charge:
0
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
228.203g/mol
Monoisotopic Mass:
228.042g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
66.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.3  
Literature
Title Journal
Phase II Conjugates of Urolithins Isolated from Human Urine and Potential Role of β-Glucuronidases in Their Disposition. Drug metabolism and disposition: the biological fate of chemicals 20170601
In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T24 cells. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20130901
Biological significance of urolithins, the gut microbial ellagic Acid-derived metabolites: the evidence so far. Evidence-based complementary and alternative medicine : eCAM 20130101
Intestinal ellagitannin metabolites ameliorate cytokine-induced inflammation and associated molecular markers in human colon fibroblasts. Journal of agricultural and food chemistry 20120912
Ellagic acid and polyhydroxylated urolithins are potent catalytic inhibitors of human topoisomerase II: an in vitro study. Journal of agricultural and food chemistry 20120912
Ellagitannin metabolites, urolithin A glucuronide and its aglycone urolithin A, ameliorate TNF-α-induced inflammation and associated molecular markers in human aortic endothelial cells. Molecular nutrition & food research 20120501
Metabolism of oak leaf ellagitannins and urolithin production in beef cattle. Journal of agricultural and food chemistry 20120328
Urolithin as a converging scaffold linking ellagic acid and coumarin analogues: design of potent protein kinase CK2 inhibitors. ChemMedChem 20111209
In vivo anti-inflammatory and antioxidant properties of ellagitannin metabolite urolithin A. Bioorganic & medicinal chemistry letters 20111001
Metabolites of the ellagitannin geraniin and their antioxidant activities. Planta medica 20110701
Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. The Journal of nutritional biochemistry 20100801
Effects of fruit ellagitannin extracts, ellagic acid, and their colonic metabolite, urolithin A, on Wnt signaling. Journal of agricultural and food chemistry 20100414
Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice. Molecular nutrition & food research 20100301
Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro. Cancer prevention research (Philadelphia, Pa.) 20100101
Effects of pomegranate chemical constituents/intestinal microbial metabolites on CYP1B1 in 22Rv1 prostate cancer cells. Journal of agricultural and food chemistry 20091125
Urolithins, intestinal microbial metabolites of Pomegranate ellagitannins, exhibit potent antioxidant activity in a cell-based assay. Journal of agricultural and food chemistry 20091111
Interaction of polyphenolic metabolites with human serum albumin: a circular dichroism study. Chemical & pharmaceutical bulletin 20090901
A concise synthesis of glucuronide metabolites of urolithin-B, resveratrol, and hydroxytyrosol. Carbohydrate research 20090727
Dissimilar in vitro and in vivo effects of ellagic acid and its microbiota-derived metabolites, urolithins, on the cytochrome P450 1A1. Journal of agricultural and food chemistry 20090624
Gene expression, cell cycle arrest and MAPK signalling regulation in Caco-2 cells exposed to ellagic acid and its metabolites, urolithins. Molecular nutrition & food research 20090601
Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects. Journal of medicinal food 20080601
Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. Journal of agricultural and food chemistry 20070919
Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. Journal of agricultural and food chemistry 20060308
Identification of urolithin a as a metabolite produced by human colon microflora from ellagic acid and related compounds. Journal of agricultural and food chemistry 20050713
Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability. Journal of agricultural and food chemistry 20050126
Properties